State Ledger
Company profile

Actinium Pharmaceuticals, Inc. CIK 1388320

Ticker
ATNM (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY 10017
Fiscal year end
2025 (FY)
Market Data
Close
$1.09
Change
+$0.01
Change %
0.46%
Volume
190

ATNM · trading date Oct 9, 2026 · previous close $1.08 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$90.0K
Net income
-$33.89M
Total assets
$51.78M
Total liabilities
$43.94M
Stockholders' equity
$7.83M
Cash & equivalents
$48.00M
Operating income
-$36.25M
Operating cash flow
-$24.58M
Capital expenditures
$104.0K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-40,274.4%
Net margin
-37,652.2%
Free cash flow
-$24.68M
Free cash flow margin
-27,426.7%
Liabilities / assets
84.9%
Equity / assets
15.1%
CapEx / revenue
115.6%
Operating cash flow / net income
0.73×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $90.0K -$33.89M $51.78M $43.94M $7.83M
2024 — -$38.24M $76.90M $44.14M $32.76M
2023 $81.0K -$48.82M $81.45M $45.07M $36.38M
2022 $1.03M -$33.02M $114.19M $47.71M $66.48M
2021 $1.14M -$24.77M $80.39M $6.84M $73.55M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 3
2026-09-10
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10017
100 PARK AVE., 23RD FLOOR
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:43 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies